Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suramin and Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme
NCT00004073Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Dec 1999
- Primary completion
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suramin in glioblastoma multiforme (GBM), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Dec 1999; status: completed.
02
Drugs
suramin
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00004073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004073.